European Pharmaceutical Contract Manufacturing Market Size, Share and Forecast 2021-2027

 The European Pharmaceutical Contract Manufacturing market is anticipated to grow at a modest CAGR of around 6.1% during the forecast period (2021-2027). The European pharmaceutical contract manufacturing market has witnessed impressive growth over the past few decades. Pharmaceutical contract manufacturing company provides cost-effective drug development and manufacturing solutions to pharmaceutical and biotech companies. In the wake of the COVID-19 pandemic, the demand for generic medicines has increased. Many pharmaceutical organizations in European countries have hired CDMO to develop more medicines and pharmaceutical products during the COVID-19 pandemic, this led to market growth.

 To Request a Sample of our Report on European Pharmaceutical Contract Manufacturing Market:  https://www.omrglobal.com/request-sample/european-pharmaceutical-contract-manufacturing-market

The availability of skilled labor, improved infrastructure, and government policies, and increasing uptake of biologics and generics are the major factors driving the growth of the European pharmaceutical contract manufacturing market during the forecast period. Pharmaceutical companies contract with CDMO to increase their capabilities of commercial production and to increase the supply of numbers of the vaccine. Besides, the rising mergers and acquisitions among market players to expand their product offerings and manufacturing units is the factor that also propelling the market growth in the European region. 

 

For instance, in February 2020, Catalent Pharma Solutions acquired MaSTherCell Global, a contract development manufacturing organization (CDMO) subsidiary of Orgenesis to further expand their product offerings for point-of-care cell therapy and the development of advanced therapy medicinal products. Moreover, in May 2019, EVER Pharma Holding Ges.m.b.H completed the acquisition of Amneal Deutschland GmbH, a subsidiary of Amneal Pharmaceuticals to extend its commercial presence in Europe. With this acquisition, EVER Pharma extended its portfolio in Germany. 

 Market Coverage

·        The market number available for – 2020-2027

·        Base year- 2020

·        Forecast period- 2021-2027

Segment Covered- 

·        By Manufacturing Process Type

·        By Product Type

·        By Route of Administration

·        By Service

Regions Covered-

·        Europe

·        UK

·        Germany

·        Italy

·        Spain

·        France

·        RoE

·        Competitive Landscape- Aenova Group, Baxter Healthcare Corp., Boehringer Ingelheim International GmbH, Catalent Inc., Famar SA, Galena Pharma Oy, Jubilant Life Sciences Ltd., Lonza Group, Patheon Inc., Pfizer CentreOne, Recipharm AB (publ), among others

 (Get 15% Discount on Buying this Report)

A full Report of European Pharmaceutical Contract Manufacturing Market is Available at: https://www.omrglobal.com/industry-reports/european-pharmaceutical-contract-manufacturing-market

 European Pharmaceutical Contract Manufacturing Market Report by Segment

By Manufacturing Process Type

·        Sterile Manufacturing

·        Non-Sterile Manufacturing

·        By Product Type

·        Over-The-Counter (OTC) Drugs

·        Active Pharmaceutical Ingredients (API)

Finished Dosage Formulation

·        Solid Dose

·        Liquid Dose

·        Injectable Dose

·        Others (Nutritional Products and Packaging)

By Route of Administration

·        Oral Administration

·        Inhaled Administration

·        Parenteral Administration

·        Others (Rectal and Vaginal)

By Service

·        R&D

·        Manufacturing

·       Non-Clinical Service (Supply Chain Management)

 Company Profiles 

·        AenovaGroup

·        Almac Group Ltd.

·        Aurena Laboratories AB

·        Baxter Healthcare Corp.

·        Beltapharm S.p.A

·        Boehringer Ingelheim International GmbH

·        Catalent Inc.

·        Cenexi SAS

·        CordenPharma International GmbH

·        Delorbis Pharmaceuticals Ltd.

·        Delpharm SAS

·        Esteve Química SA

·        Ever Neuro Pharma GmbH

·        Evonik Industries AG

·        Famar SA

·        Galena Pharma Oy

·        Gebro Pharma GmbH

·        GlaxoSmithKline PLC

·        Jubilant Life Sciences Ltd.

·        Lonza Group

·        NextPharma TechnologiesHolding Ltd.

·        Novozymes A/S

·        Onyx Scientific Ltd.

·        Patheon Inc.

·        ProBioGen AG

·        Pfizer CentreOne (Pfizer Inc.)

·        Recipharm AB (publ)

·        Samedan Ltd.

·        Saneca Pharmaceuticals AS

·        SOPHARMA AD

·        Venus Pharma GmbH

·        Vetter Pharma International GmbH

·        Wacker Biotech GmbH

Reasons for Buying from us –

1.  We cover more than 15 major industries, further segmented into more than 90 sectors.

2.  More than 120 countries are for analysis.

3.  Over 100+ paid data sources mined for investigation.

4.  Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @  https://www.omrglobal.com/report-customization/european-pharmaceutical-contract-manufacturing-market

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit Orion Market Research

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404

Comments

Post a Comment

Popular posts from this blog

European Data Backup and Recovery Market Size, Share, Analysis, Industry Report and Forecast 2019-2025

  European Data Backup and Recovery Market are expected to reach $5.7 billion in 2027, growing at a CAGR of 9.5% during the forecast period (2021-2027). Factors responsible for the growth of the market in Europe are well-developed telecommunication infrastructure, high internet penetration, high adoption of cloud-based devices among people and organization. Regulations regarding the data localization such as GDPR by the European Union and countries own data localization and protection act are providing growth to the market. Major economies which are expected to hold a considerable market are UK, Germany, France, Italy, and Spain. These economies are part of the European Union, which covers most of the continent. The aim of the European Union was to increase economic cooperation and encourage free trade among countries. To Request a Sample of our Report on European Data Backup and Recovery Market :   https://www.omrglobal.com/request-sample/european-data-backup-recovery-...
Read more

Insect Repellent Market Is Likely to Experience a Tremendous Growth by 2031

This informative Insect Repellent Market report provides new method and covers foremost regions such as Latin America, Middle East, North America, Europe, Africa and Asia Pacific. Making most out of the consumer insights and market opportunities, market players can boost up the revenue rate of their business. It also permits key organizations to make communication with customers and know their demands for making right investment in the product development. By increasing the product portfolio by referring the important market data provided in this Insect Repellent Market research report, key players can grow and expand their business forward. Continuously developing customer demands are also described in this global report to help new entrants make required changes in the final product launch and then bring into the market. It becomes easy for key players to prioritize the demands and requirements of target audience and have complete understanding of end-user experience with the help o...
Read more

Asia-Pacific Urban Air Mobility Market Growth, Size, Share, Industry Report and Forecast 2019-2025

The Asia-Pacific urban air mobility market is estimated to grow at a CAGR of 12.6% during the forecast period. The Asia-Pacific urban air mobility market is segmented on the basis of component and operation. Based on the component, the market is further segmented into infrastructure and platform. The infrastructure segment is further segmented into charging stations, traffic management, and others whereas, the platform segment is further classified into air taxi, personal air vehicle, air ambulance, and others. The platform segment dominated the global urban air mobility market. To Request a Sample of our Report on Asia-Pacific Urban Air Mobility Market :   https://www.omrglobal.com/request-sample/asia-pacific-urban-air-mobility-market Asia-Pacific is home to several emerging economies and is seen as the potential market for the UAM owing to growing urbanization coupled with increasing traffic congestion and increasing high-income groups in the region. The growth of the As...
Read more